Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Senior scientist boosts team at RSSL
Senior scientist boosts team at RSSL
Together with a new physical sciences laboratory manager
Joerg Reinhardt to leave Bayer HealthCare
Joerg Reinhardt to leave Bayer HealthCare
He will become director and non-executive chairman at Novartis
Particle Sciences appoints director of formulation and process development
Particle Sciences appoints director of formulation and process development
Deepak Tiwari joins the company with 18 years of pharma development experience
Microbiology specialist joins Cherwell Laboratories
Microbiology specialist joins Cherwell Laboratories
Abdulmajeed Raji takes up the newly created position
Peder Holk Nielsen to become president and CEO of Novozymes
Peder Holk Nielsen to become president and CEO of Novozymes
With effect from 1 April
Rieke Dispensing appoints European sales director
Rieke Dispensing appoints European sales director
Nicolas Lemaigre-Voreaux will drive growth throughout Europe, the Middle East and Africa
Bayer Technology Services appoints head of Operation Support and Safety
Bayer Technology Services appoints head of Operation Support and Safety
Thomas Steckenreiter takes role as Norbert Kuschnerus retires
John Reed to join Roche Pharma Research and Early Development
John Reed to join Roche Pharma Research and Early Development
Takes up role as head of pRED in April
AstraZeneca makes changes to senior executive team
AstraZeneca makes changes to senior executive team
Will see departure of Martin Mackay and Tony Zook
Lundbeck appoints VP of global pricing and market access
Lundbeck appoints VP of global pricing and market access
Plans launch of three products this year
Andrea Rappagliosi becomes president of Vaccines Europe
Andrea Rappagliosi becomes president of Vaccines Europe
He is VP of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD
Tim Mayleben rejoins Esperion as president and CEO
Tim Mayleben rejoins Esperion as president and CEO
Founder Roger Newton will become chairman and CSO
Bayer names Early Excellence in Science prize winners
Bayer names Early Excellence in Science prize winners
Three young scientists are awarded €10,000 each
SCM strengthens quality team
SCM strengthens quality team
Appoints Mark Edwards as Quality Assurance director
AMRI promotes Richard Saffee to VP and general manager of large-scale manufacturing
AMRI promotes Richard Saffee to VP and general manager of large-scale manufacturing
Will drive synergies between locations in India, the UK and the US
Sanofi appoints chairman of SDSAC
Sanofi appoints chairman of SDSAC
Dr Gary Nabel succeeds Dr Richard Klausner
Previous
1
…
146
147
148
149
(current)
150
151
152
…
213
Next
Trending Articles
MasterControl strengthens executive leadership team with two key appointments
Wynn Clayton joins as CFO while Ian Ball is promoted to chief sales officer to support the company’s next phase of growth
MHRA scientific leader recognised in 2026 King's Birthday Honours
Dr Nicola Rose receives OBE for services to science and public health
Servomex appoints new Global Sales Director
Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis
Hansa Biopharma appoints Fredrik Röök as VP Business Development
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
Ardena appoints Ariane de Ganck as Chief Scientific Officer
Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and complex therapies, today announced the appointment of Ariane de Ganck, PhD, as Chief Scientific Officer
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all